| PRIVILEDGE - ALLIANZ ALL CHINA EQUITY (EUR) M CAP SYST. HDG | RVI CHINA | 33,76% | 16,24% | -27,92% | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 USD | BIOTECNOLOGÍA | 33,75% | 87,47% | 88,88% | · |
| AMUNDI FUNDS LATIN AMERICA EQUITY I USD (C) | RVI LATINOAMÉRICA | 33,74% | 49,41% | 59,17% | 115,11% |
| DWS INVEST LATIN AMERICAN EQUITIES NC | RVI LATINOAMÉRICA | 33,74% | 36,49% | 48,19% | 166,11% |
| PICTET - BIOTECH R USD | BIOTECNOLOGÍA | 33,74% | 48,82% | 28,34% | 54,75% |
| JPM EUROPE STRATEGIC VALUE I (ACC) EUR | RVI EUROPA VALOR | 33,72% | 76,86% | 118,36% | 127,48% |
| ABANTE GLOBAL FUNDS - ABANTE EUROPEAN QUALITY EQUITY B EUR CAP | RVI EUROPA | 33,71% | 71,73% | 85,24% | 89,81% |
| INVESCO STOXX EUROPE 600 OPTIMISED UTILITIES UCITS ETF ACC | UTILITIES | 33,70% | 49,75% | 53,55% | 121,43% |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR | BIOTECNOLOGÍA | 33,69% | 80,85% | · | · |
| JPM EUROPE STRATEGIC VALUE C (ACC) EUR | RVI EUROPA VALOR | 33,69% | 76,63% | 117,90% | 126,56% |
